As a recognized player, we develop and manufacture high-value-added active pharmaceutical ingredients and chemical products for global healthcare leaders.
Joining Minakem means becoming part of a company
with unique expertise: we combine technological innovation and scientific expertise to offer tailored, high-quality solutions to our clients. By working at Minakem, you actively contribute to improving the health and quality of life of patients worldwide.
It also means joining a close-knit team: While our ambition is international, we remain an organization where every employee matters, with supportive and dedicated teams. Our culture is founded on strong values that make Minakem a place where you can thrive professionally, express and develop your full potential while staying true to your principles.
By joining Minakem, you will be part of an exciting human and scientific adventure, in a stimulating environment where your ideas matter.
Do you share our ambition and values? Explore our opportunities and choose a meaningful career.

Our Missions
Since 2005, our mission has been to promote innovative and more environmentally friendly pharmaceutical manufacturing technologies to produce high-quality active pharmaceutical ingredients (APIs) and intermediates.
By placing people and excellence at the heart of our priorities, our teams in France, Belgium, and Canada support clinical research and commercialization throughout the product lifecycle.
Every day, we work to improve the quality of life of patients worldwide, thanks to the commitment of our 600 employees passionate about chemistry and life sciences.
Our Values
At Minakem, we are guided by a set of core values that define our daily actions. Each of these values, illustrated below, builds upon the others and contributes to creating a clear and consistent code of conduct for the entire organization.

“Building a respectful future where everyone feels safe and supported.”
Respect is at the heart of every interaction within the Minafin Group, whether with colleagues, clients, partners, or other stakeholders.
The company values and encourages respectful initiatives in all its activities.
Minafin’s collaborations and partnerships are also based on respect. These alliances are established with the aim of creating value and fostering an environment of mutual trust.

“United as a team, we pursue a common goal: the success of all those we serve. We move forward and succeed as one.”
We firmly believe in the power of collaboration. Within the Minafin group, regardless of our role, we work together to achieve our shared ambition.
We recognize the individual talents that are the strength of our collective success.
Together, we are committed to promoting healthy lives, our legacy, by developing essential ingredients to provide healthcare solutions.

“Challenges are stepping stones to success, not obstacles.”
Perseverance is our driving force. We believe that with resilience and commitment, challenges can be transformed into opportunities.
Our determination drives us forward, not only to achieve our ambitions but also to leave our mark on the industry we serve.

“Ethics is not just a code; it represents the principle that guides each of our actions.”
We place honesty, transparency, and respect for commitments at the heart of our practices.
These extend to all partners who contribute together to our activities.
We firmly believe that ethical conduct fosters lasting and trusting relationships and ensures respect for our commitments to all stakeholders.

“Promises made, promises kept.”
We believe in the value of responsibility, both individual and collective, and we ensure that we honor each of our commitments.
We trust our employees by entrusting them with responsibilities, allowing them to actively contribute to the company’s success and grow in their roles.
Our commitment to our partners and customers is to offer the best products and services, ensuring impeccable compliance.
Each employee strives to respect these standards, thus guaranteeing our reliability in the actions we undertake.

A Positive Impact for All
All of these values work together to create a strong and dynamic corporate culture, aimed at generating a positive impact for our clients, our partners, and patients. Each of these values is essential, and every member of Minakem can contribute to their realization on a daily basis.
Together, Towards a Promising Future
Guided by our values, we are convinced that Minakem is capable of meeting the challenges of the present and building a promising future for all of its stakeholders.
Our History
Minakem is a manufacturer of active pharmaceutical ingredients (APIs) with four production sites, three in Europe and one in Canada. The company also specializes in the manufacture of pharmaceutical intermediates and benefits from over 65 years of experience and heritage.

Founded as « Laboratoires du Bois de Boulogne » near Paris, laying the groundwork for future innovation. Company’s foundation by Mr. Claude Dufour in the western suburb of Paris (Boulogne under the name of «Laboratoires du Bois de Boulogne» and renamed the company SEAC.

Relocation to Beuvry-la-Forêt, establishing our current headquarters in Northern France. This site, known as Minakem Beuvry-la-Forêt since 2005, boasts a long history of expertise.

Construction of the Louvain-la-Neuve Site for Vinca Alkaloids production, owned by Ajinomoto Omnichem since 1989.

Construction of the new Plant in Dunkirk by AstraZeneca.

Louvain-la-Neuve site major upgrade to allow handling of highly actives and cytotoxic products under strict containment (OEB class 5).

A pivotal year. Minakem takes over SEAC operations, acquiring a wealth of resources including R&D labs, a pilot plant, and significant manufacturing capabilities. This marked the official launch of Minakem as we know it today.

Expansion through the acquisition of the Dunkirk plant, increasing our reactor capacity by 150m3. This move also expanded our technology base with steroid manufacturing, micronization, and injectable capabilities.

Our most recent acquisition involved Ajinomoto’s business and site, significantly enhancing our expertise in high-potency active pharmaceutical ingredients (HAPIs). This strategic move allows us to develop cutting-edge pharmaceutical productions requiring high-level containment facilities.

Continued commitment to innovation! A major investment of €40 million adds 30m3 of capacity to manufacture commercial small molecules APIs.

Last acquisition to date, Minakem takes over Delmar’s business and site in Montreal.
Join the Adventure. Be part of a dynamic and innovative team where every challenge is an opportunity to grow. Together, let’s shape the future
Our Sites

Development and commercial production of small molecule APIs
- Fit for purpose process and analytical development with timely and robust scale-up from clinical to commercial supply
- Home to Minakem’s R&D Center of Excellence

Development and commercial production of small molecule APIs and Steroids
- Fit for purpose process and analytical development with timely and robust scale-up from clinical to commercial supply
- Dedicated steroid manufacturing unit

Commercial production of small molecule APIs
- Large scale manufacturing

Development and commercial production of small molecule Highly Potent APIs (HPAPIs) and Steroids
- Fit for purpose process and analytical development with timely and robust scale-up from clinical to commercial supply
- OEL: 0.1µg/m3/shift and Industrial Preparative HPLC



































